The Effect of Menopausal Hormone Therapies on Breast Cancer: Avoiding the Risk
- PMID: 26316245
- PMCID: PMC4555991
- DOI: 10.1016/j.ecl.2015.05.007
The Effect of Menopausal Hormone Therapies on Breast Cancer: Avoiding the Risk
Abstract
Estrogen and P treatment results in greater risk of breast cancer than placebo. Treatment with estrogen alone does not increase the risk of breast cancer, may be used by women who have had a hysterectomy, and may even result in a decreased risk of breast cancer. Continued research seeks to improve the understanding of the interplay between estrogen and progestogens that predispose to adverse effects on breast tissue. Caution over this hypothesized benefit is warranted until it is substantiated by data on the incidence of breast cancer in tissue selective estrogen complex users.
Keywords: Breast cancer; Estrogens; Hormone therapy; Menopause; Progestogen.
Copyright © 2015 Elsevier Inc. All rights reserved.
References
-
- Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117(12):1016–1037. - PubMed
-
- Stefanick ML, Anderson GL, Margolis KL, et al. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. Jama. 2006;295(14):1647–1657. - PubMed
-
- Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2003;362(9382):419–427. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
